CleanGo Innovations Inc. (CSE: CGII) has released its unaudited Q2 2026 financial results and a comprehensive six-month corporate update covering the fiscal period ended June 30, 2026. The announcement outlines significant milestones including international expansion into South America and the Mediterranean, the launch of its fungal bioremediation product MycoSet™, and the closing of a non-brokered private placement. Investors may be watching the update closely as the company continues to broaden its global footprint across the oil and gas, industrial, and environmental sectors.
Key Points
- CleanGo Innovations Inc. (CSE: CGII; OTCQB: CLGOF; FRA: APO.F) issued a six-month corporate update on August 26, 2026.
- The company completed its first South American shipment, signed a Mediterranean marine partnership, and launched the MycoSet™ Remediation Suite.
- A non-brokered private placement closed at $0.77 per unit for aggregate gross proceeds of $719,716.80 on 934,696 units.
- Investors may be watching how the MycoSet™ laboratory results and CG-P100 product line translate into commercial traction.
CleanGo Enters South America and Mediterranean With New Commercial Agreements
In January 2026, CleanGo dispatched its first shipment to Indioquímica S.A. in Argentina — a 6,000-litre deployment representing the company's official entry into South American oil, gas, and heavy industrial markets. The following month, the company signed an agreement with WSR Services LTD in Cyprus to launch CleanGo Marine, providing eco-friendly vessel maintenance solutions exclusively for the Mediterranean shipping industry. The release states these moves mark meaningful steps in CleanGo's international commercialisation strategy.
MycoSet™ Remediation Suite Launches Following AgritechBC Acquisition
CleanGo launched its MycoSet™ Remediation Suite in January 2026, describing it as a fungal-based living system designed to restore contaminated soil and water. The launch followed the company's entry into a definitive Stock Purchase Agreement dated March 27, 2026, to acquire a 49% equity interest in AgritechBC Solutions Inc. In March 2026, independent third-party laboratory testing results indicated that MycoSet™ significantly accelerates biodegradation of petroleum pollutants, according to the release. The company also confirmed it elected not to proceed with a previously proposed acquisition of Freia Farmaceutici Srl following due diligence.
CG-P100 Pipeline Product and Kubera Black Subsidiaries Broaden Portfolio
In July 2026, CleanGo launched CG-P100, a product line formulated for pipeline maintenance, decontamination, and bioremediation in oil and gas and water desalination sectors. Separately, subsidiary Kubera Black Energy launched a global Gain of Revenue (GOR) program targeting oil well operators, while Kubera Black Technologies established a U.S. real estate hub leveraging the federal Guiding and Establishing National Innovation for U.S. Stablecoins Act regulatory framework. The announcement presents these developments as extensions of CleanGo's diversification across environmental and asset-management verticals.
Private Placement and Warrant Amendments Strengthen CleanGo's Capital Structure
CleanGo closed a non-brokered private placement of 934,696 units at $0.77 per unit, generating aggregate gross proceeds of $719,716.80. Earlier in February 2026, the company entered debt-settlement agreements through share issuances to preserve cash for global operations. In April 2026, amendments were made to an aggregate of 1,000,000 common share purchase warrants to provide holders with greater flexibility. The immediate share price impact was not clear from available public information.




Please wait processing your request...